Relaying what matters next.
The Relay is a new media project dedicated to covering slightly futuristic domains such as artificial intelligence, space exploration, longevity science, crypto and blockchain, advanced biology, and defense technologies. Our mission is to capture the signals of tomorrow and relay them forward with clarity, depth, and context.
What's happening today?
In vivo CAR-T goes clinical: unlocking senescence therapy
September 2025 delivered two thresholds for cell therapy: the first human data that T cells can be programmed into CAR T in the body without conditioning, and the first randomized win for CAR T in a solid tumor. Together they open a credible path to senescent cell clearance in common aging diseases.
China’s Tianwen‑2 launches to a quasi‑moon, then 311P
China launched Tianwen-2 to sample Earth’s quasi-satellite Kamo‘oalewa and return material by 2027 before continuing on to active asteroid 311P/PANSTARRS. The dual-target mission showcases solar-electric propulsion and has clear planetary-defense value.
Mitochondria’s Breakthrough Year: Rare Cures to Longevity
Summer 2025 delivered three milestones for mitochondrial medicine: births after mitochondrial donation in the UK, an FDA-cleared Phase II cell therapy for Pearson syndrome, and precise base edits in animals and patient cells. Here is what is real, what is risky, and how this momentum could shape healthspan.
The Post-IRA Sprint: States rush to lock wind and solar
With federal timelines pulled forward, states are fast‑tracking wind and solar awards to qualify before the 2027 placed‑in‑service cutoff. Here’s how developers are retooling, who benefits, and how to avoid a 2028 project cliff.
Tether’s mega-raise and USAT pivot reset the stablecoin race
Reports in late September indicate Tether is lining up a multibillion private raise and a U.S.-focused stablecoin, USAT. This analysis explains what that signals for compliance and institutions, how market share could shift, and how builders should prepare through Q4 2025.
Sky’s migration crunch: penalties, stUSDS, and the Q4 reset
Sky has activated a quarterly penalty on MKR-to-SKY conversions and advanced stUSDS onboarding. Here’s how the new economics, governance rules, and yield routes will push upgrades, rewire liquidity, and shape DeFi decisions through Q4 2025.
Microwave Shields Go Big in 2025: Counter-Drone Hits Scale
A 49-drone swarm fell in seconds and the Army signed for next-gen IFPC-HPM. Here is how high-power microwaves are moving from flashy demos to layered air defense at scale in 2025.
Inside the Corona: Parker’s 2025 Data Will Rewire Space Ops
Parker Solar Probe’s 2025 inside-the-corona passes are turning solar physics into engineering data. Live readings of wind lanes, magnetic switchbacks, and CME birth zones now map directly to decisions for crews, constellations, and power grids.
Dogs-first longevity passes a real FDA test at Loyal
Loyal’s senior-dog pill just passed the FDA’s Reasonable Expectation of Effectiveness bar, opening a path to conditional approval. Here is what RXE certifies, why the veterinary-first route matters, and how a 2026 launch could become real.
Dynamic Line Ratings Slip Past 2025 as Grid Needs Surge
FERC-approved extensions push dynamic and ambient-adjusted line ratings into 2026 to 2028, leaving billions in congestion and curtailment on the table. Here is what slipped, why it matters, and a practical plan to recover speed.
SDA’s Tranche 1 lifts off as the LEO battle network arrives
Before dawn on September 10, 2025, SDA’s first Tranche 1 mission put a laser‑linked mesh of small satellites into low Earth orbit. Here is how this Transport Layer cuts minutes from the kill chain, why optical crosslinks and on‑orbit autonomy matter, and what Tranche 2 brings next.
World Chain uses Chainlink CCIP to make WLD natively cross chain
On September 25, 2025, World Chain enabled native WLD transfers between Ethereum and World Chain using Chainlink CCIP and the Cross-Chain Token standard. The move replaces fragile custom bridges with audited rails and pushes cross-chain toward enterprise-grade interoperability.
FDA’s LDT reversal reboots the aging biomarker race
With the FDA’s 2024 LDT rule vacated and CLIA back in the driver’s seat, aging biomarkers from methylation clocks to proteomic panels are racing into clinics. Here is what reopens, who benefits now, and a 6 to 12 month playbook to do it credibly.
BepiColombo’s reroute sets up a richer Mercury campaign
ESA’s BepiColombo will now target Mercury orbit in November 2026 after a thruster power shortfall. The reroute preserves core goals, adds rich flyby science, and times the main campaign with an active Sun that could supercharge magnetosphere and exosphere results.
NIETCs Go Prime Time: Corridors Set 2026-2032 Build
With three federal corridors advancing and backstop siting clarified, transmission finally has a real near-term clock. Here is how DOE and FERC just set up a 2026 to 2032 build window, who stands to benefit first, and where fights will flare.
Tempo’s testnet makes onchain checkout finally feel real
On September 4, 2025, Stripe and Paradigm unveiled Tempo, a payments-first blockchain in private testnet. With sub-second finality, stablecoin-native fees, and issuer-neutral conversion, it pushes onchain checkout and payouts toward mainstream scale.
Sentinel’s new-silo pivot: America’s biggest defense build
The Air Force’s decision to build hundreds of new ICBM silos turns Sentinel from a missile recapitalization into a five-state civil-works megaproject. Here’s what broke reuse, where the real chokepoints are, and how to move faster without sacrificing nuclear surety.
Office becomes an agent runtime with Copilot’s new modes
Microsoft just flipped the script on Word and Excel. With Copilot’s new Agent Mode and a cross app Office Agent, Office becomes a place where software agents plan, act, and leave an audit trail you can trust.

















